Login/Sign Up
₹1945
(Inclusive of all Taxes)
Get Free delivery (₹99) with
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's is indicated for weight management when used together with a reduced-calorie diet and increased physical activity in individuals with obesity. It also helps to lower the risk of serious heart-related problems, such as heart attack and stroke, in people with obesity or overweight and established heart disease.
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation. It works by slowing the emptying of food from the stomach, increasing feelings of fullness, and reducing hunger, which helps lower calorie intake and support weight management. It also helps the body regulate blood sugar levels and supports overall metabolic health.
Additionally, by supporting weight loss and improving metabolic health, Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's may help lower the risk of serious heart-related problems, such as heart attack and stroke, in people who are overweight or obese and have heart disease.
In some cases, Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's may cause side effects such as nausea, vomiting, diarrhoea, constipation, abdominal discomfort, dizziness, or altered taste. Talk to your doctor if the side effects persist or worsen.
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's is available in a pre-filled multi-dose pen that allows flexible dosing. It features an easy-to-use dialer for accurate dose delivery and is designed for convenient self-administration. Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's is not recommended for use in children, during pregnancy, or while breastfeeding.
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's is used to treat various medical conditions. The detailed uses are as follows:
Caution
You are recommended to avoid alcohol consumption while taking Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's. It could lead to increased adverse events.
Unsafe
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's should not be used during pregnancy as there is a potential risk of harm to the unborn baby. Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's is not recommended for women who are pregnant, planning to conceive soon, or not using reliable contraception during therapy.
Unsafe
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's is not recommended during breastfeeding as its safety is not established.
Caution
Generally does not impair ability to drive; however, dizziness or low blood sugar (if combined with other drugs) may affect alertness.
Caution
Inform your doctor before receiving Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's if you have a pre-existing or a history of liver disease. Your doctor will prescribe only if the benefits outweigh the risks.
Caution
Inform your doctor before receiving Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's if you have a pre-existing or a history of kidney disease. Your doctor will prescribe only if the benefits outweigh the risks.
Consult your doctor
It is not recommended for use in children under 18 years of age, as the safety and efficacy have not been established.
Safe if prescribed
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's is used in patients with heart disease to help reduce the risk of major adverse events such as heart attack and stroke. However, people who have an irregular heartbeat or a very fast heart rate may need closer monitoring during treatment to make sure the medicine is safe and working properly.
Caution
Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's should be used with caution in elderly patients, as it may be associated with a higher risk of fractures.
Have a query?
Keep Refrigerated. Do not freeze.Prepaid payment required.
Drug-Drug Interactions: Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's potentially interacts with certain medications used to treat certain cancers (e.g., bexarotene, capivasertib), certain general anaesthetics (e.g., desflurane, enflurane, etomidate, fospropofol, halothane, isoflurane, ketamine), antibiotics (e.g., gatifloxacin), certain insulin or sulfonylureas (e.g., glimepiride, glyburide) and certain GLP‑1 receptor agonists or similar weight-loss medications (e.g., liraglutide, tirzepatide).
Drug-Food Interactions: There are no significant food restrictions with Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's. However, limit alcohol intake as it can worsen nausea and vomiting and may increase the risk of low blood sugar, particularly if you are using other diabetes medicines.
Drug-Disease Interactions: If you have a history of suicidal behaviour and ideation, thyroid cancer, hypoglycemia, pancreatitis, retinopathy and GI adverse reactions. Inform your doctor before starting treatment with Noveltreat 0.5mg/0.5ml Prefilled Pen Solution For Injection 1's. These conditions may require close monitoring or adjustments to your therapy.
Login/Sign Up
Login/Sign Up
Alkem Laboratories Ltd
₹375
(₹375.0 per unit)
Novo Nordisk India Pvt Ltd
₹8100
(₹5400.0/ 1ml)
Novo Nordisk India Pvt Ltd
₹8100
(₹5400.0/ 1ml)
Disclaimer

RX
RX
RX